MP Biomedicals, LLC Agrees to Sell Rapid Diagnostics Division< Back to News
Aug 16, 2017
Santa Ana, California, August 16, 2017 – MP Biomedicals LLC ("MP Biomedicals"), a leading provider of life science reagents, fine chemicals and diagnostic products for over 50 years, has agreed to sell the assets of their Rapid Diagnostics division to LumiQuick Diagnostics Inc. ("LumiQuick") a manufacturer of high quality point of care tests and other immunoassay kits.
Both MP Biomedicals and LumiQuick are excited about this transaction. LumiQuick has developed a broad range of drugs of abuse tests along with many other assays since it was founded in 2006. With the expertise and R&D resource of LumiQuick, Rapid Diagnostics will be able to continue to provide its customers high quality products and new tests under LumiQuick’s signature QuickProfile™ brand or OEM packaging.
Under the terms of the agreement MP Biomedicals will sell to LumiQuick all rights, title and interest in the assets of the Rapid Diagnostics division. All customers and customer orders will be transferred to LumiQuick as of August 31st, 2017. The Rapid Diagnostics division will continue to operate at its current premise under the same quality and manufacturing systems. Customers needing support or further information should contact LumiQuick directly beginning September 1st, 2017.
LumiQuick Diagnostics Inc.
2946 Scott Blvd.
Santa Clara, California 95054, USA
E-mail: [email protected]